Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

St. Louis, USA
1005 North Warson Road
St. Louis, MO, 63132
USA

People

President and CEO
Senior VP and CFO
VP Business Development and CTO
Vice President, Product Development
Chief Scientist
Vice President, Intellectual Property
Board of Directors
Board of Directors
Show All People

Acquisitions

Funding

TOTAL $7M
FUNDING TOTAL $7M
Series A, 1/2013
RockPort Capital Partners
Open Prairie
Pangaea Ventures
$7M

Tags

NewLeaf Symbiotics

NewLeaf Symbiotics was formed in 2012 to develop and commercialize one of the most prevalent, beneficial bacteria found in nature: PPFMs (Pink Pigmented Facultative Methylotrophs). NewLeaf Symbiotics is the exclusive licensee of a number of patents on the use of this family of bacteria. NewLeaf Symbiotics has also filed its own related patents, and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials and expects to commercialize and license products beginning in 2014.

Recent Milestones

Videos

Screenshots

NewLeaf Symbiotics screenshot
Above: NewLeaf Symbiotics
Uploaded: 1/11/13

Sources

  1. NewLeaf Symbiotics acquires Intuitive Genomics (intuitivegenomics.com) [edit]
  2. NewLeaf Symbiotics Raises $7 Million in Series A Financing from RockPort Capital, Open Prairie Ventures and Pangaea Ventures (finance.yahoo.com) [edit]
Edit This Page
Last Edited 12/6/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy